The burden of cancer in New Zealand: A comparison of incidence and DALY metrics and its relevance for ethnic disparities

Australian and New Zealand Journal of Public Health

Volumn 37, Issue 3, 2013, Pages 218-225

  Costilla, Roy ^a   Tobias, Martin ^b   Blakely, Tony ^c  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Burden of disease; Cancer; DALY; Incidence; Markov models; New Zealand; YLD; YLL

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; COMPARATIVE STUDY; COST OF ILLNESS; DISABLED PERSON; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH DISPARITY; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NEW ZEALAND; NEWBORN; PRESCHOOL CHILD; PROBABILITY; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT; ARTICLE; NEOPLASM; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DISABLED PERSONS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MARKOV CHAINS; MIDDLE AGED; NEOPLASMS; NEW ZEALAND; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; YOUNG ADULT;

EID: 84879297334     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/1753-6405.12062     Document Type: Article

References (29)

1. Ministry of Health. Mortality and Demographic Data 2009. Wellington (NZ): Government of New Zealand; 2012.
2. Ministry of Health. Cancer Projections Incidence 2004-08 to 2014-18. Wellington: Government of New Zealand; 2010.
3. Ministry of Health. Cancer in New Zealand: Trends and Projections. Wellington: Government of New Zealand; 2002.
4. Blakely T, Shaw C, Atkinson J, Cunningham R, Sarfati D. Inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-86 to 2001-04. Cancer Causes Control. 2011;22(9):1307-18.
5. Murray J, Lopez A. The Global Burden of Disease. A comprehensive assessment of the mortality from disease, injuries, and risk factors in 1990 and projected to 2020. Boston (MA): Harvard School of Public Health; 1996.
6. Ministry of Health. The Burden of Disease and Injury in New Zealand. Wellington: Government of New Zealand; 2001.
7. Harvard Initiative for Global Health, Institute for Health Metrics and Evaluation UoW, John Hopkins University, University of Queensland, World Health Organization. The Global Burden of Diseases, Injuries and Risk Factors Study: Operations Manual. Brisbane (AUST): University of Queensland, Queensland Centre for Mental Health Research; 2008.
8. Blakely T, Shaw C, Atkinson J, Tobias M, Bastiampillai N, Sloane K, et al. Cancer Trends: Trends in Incidence by Ethnic and Socioeconomic Group, New Zealand 1981-2004. Wellington: New Zealand Ministry of Health; 2010.
9. Blakely T, Costilla R, Tobias M. Burden of Cancer. New Zealand 2006. Wellington: Nesw Zealand Ministry of Health; 2010.
10. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39(2):598-610.
11. Dickman P W, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64.
12. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The Burden of Disease and Injury in Australia 2003. Canberra (AUST): Australian Institute of Health and Welfare; 2007.
13. Talbäck M, Rosén M, Stenbeck M, Dickman P W. Cancer patient survival in Sweden at the beginning of the third millennium - predictions using period analysis. Cancer Causes Control. 2004;15(9):967-76.
14. Centre for Epidemiology. National Board of Health and Welfare. Cancer Patient Survival in Sweden 1980-2002. Stockholm (SWE): National Board of Health and Welfare (Socialstyrelsen); 2004 [cited 2013 May 2]. Available from: http://192.137.163.49/pxweb2006/cancersurvival/RSR/FrameRSR.html
15. New Zealand Health Information Service. Cancer Patient Survival. Covering the Period 1994-2003. Wellington (NZ): New Zealand Ministry of Health; 2006.
16. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray C J L. Global Burden of Disease and Risk Factors. New York (NY): Oxford University Press; 2006.
17. Pharmac. Prescription for Pharmocoeconmic Analysis: Methods for Cost Utility Analysis. Version 2.1. Wellington (NZ): Pharmac; 2012.
18. Ministry of Health. Cancer Incidence Projections: 1999-2003 Update. Wellington (NZ): Government of New Zealand; 2008.
19. Jeffreys M, Stevanovic V, Tobias M, Lewis C, Ellison-Loschmann L, Pearce N, et al. Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health. 2005;95(5):834-7.
20. Robson B, Purdie G, Cormack C. Unequal Impact: Māori and Non-Māori Cancer Statistics 1996-2001. Wellington (NZ): New Zealand Ministry of Health; 2006.
21. Fernandez De Larrea-Baz N, Alvarez-Martin E, Morant-Ginestar C, Genova-Maleras R, Gil A, Perez-Gomez B, et al. Burden of disease due to cancer in Spain. BMC Public Health. 2009;9(1):42.
22. Spiegelhalter D, Best N. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med. 2003;22(23):3687-709.
23. Whyte S, Walsh C, Chilcott J. Bayesian calibration of a natural history model with application to a population model for colorectal cancer. Med Decis Making. 2011;31(4):625-41.
24. Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust. 2008;188(1):36-40.
25. Stouthard M, Essink-Bot M-L, Bonsel GJ, Barendregt J, Kramer P, Van De Water H, et al. Disability Weights for Diseases in The Netherlands. Rotterdam (NLD): Erasmus University, Department of Public Health; 1997.
26. Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, et al. Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health. 2009;64(2):117-23.
27. Blakely T, Costilla R, Soeberg M. Cancer Excess Mortality Rates Over 2006-2026 for ABC-CBA. Wellington (NZ): University of Otago, Department of Public Health; 2012.
28. Kvizhinadze G, Ikeda T, Blakely T. Modelling Options for ABC-CBA. Wellington (NZ): University of Otago, Department of Public Health; 2012.
29. Ministry of Health. New Zealand Burden of Disease, Injury and Risk Factors Study. Wellington (NZ): Government of New Zealand; Unpublished observations.